Enabling Research

Major disease research programs depend upon pursuit of a comprehensive understanding of the cellular and molecular basis of disease and response to potential therapeutics. Our wide range of technology platforms facilitate analysis at the gene, protein, or cellular level. Our scientific expertise is enhanced by active participation and collaboration with leaders in the areas of molecular biology, protein biology, cell biology, and chemistry.  We understand the etiology of clinically relevant diseases including cancer, neurodegeneration, autoimmune disease, diabetes, obesity, and more. We enable basic research in the fields of protein synthesis, folding, degradation, gene expression, cell death pathways, and cellular responses to stress. Our portfolio of assay kits, dyes, probes, small molecules, antibodies, proteins, and peptides are reliable, extensively validated, and backed by over 175,000 publications in peer-reviewed journals.